Ads
related to: esophoria prism correction system in skin tightening machineamazon.com has been visited by 1M+ users in the past month
theayurvedaexperience.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Where appropriate, prismatic correction can be used, either temporarily or permanently, to relieve symptoms of double vision. In specific cases, and primarily in adult patients, botulinum toxin can be used either as a permanent therapeutic approach, or as a temporary measure to prevent contracture of muscles prior to surgery
Radio-frequency skin tightening. Radio-frequency skin tightening is an aesthetic technique that uses radio frequency (RF) energy to heat skin with the purpose of stimulating cutaneous collagen, elastin and hyaluronic acid production in order to reduce the appearance of fine lines and loose skin.
Roof prism. A roof pentaprism used in Single-lens reflex cameras; the lower right face is the roof ( dach ). A roof prism, also called a Dachkanten prism or Dach prism (from German: Dachkante, lit. "roof edge"), is a reflective prism containing a section where two faces meet at a 90° angle, resembling the roof of a building and thus the name.
Sensitive skin, also known as sensate skin or electronic skin (e-skin), is an electronic sensing skin placed on the surface of a machine such as a robotic arm. The goal of the skin is to sense important environmental parameters—such as proximity to objects, heat, moisture, and direct touch sensations.
Electrodermal activity. Electrodermal activity ( EDA) is the property of the human body that causes continuous variation in the electrical characteristics of the skin. Historically, EDA has also been known as skin conductance, galvanic skin response (GSR), electrodermal response (EDR), psychogalvanic reflex (PGR), skin conductance response (SCR ...
Zeltiq Aesthetics is a subsidiary of AbbVie based in Pleasanton, California that markets and licenses devices used for cryolipolysis procedures. The company was founded in 2005 and raised $75 million in funding before going public in 2011. It was acquired by Allergan in February 2017 for $2.48 billion. [1] [2] [3] Which was then acquired by ...